» Articles » PMID: 28620094

An Interrupted Time Series Analysis to Determine the Effect of an Electronic Health Record-Based Intervention on Appropriate Screening for Type 2 Diabetes in Urban Primary Care Clinics in New York City

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2017 Jun 17
PMID 28620094
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the impact of a health system-wide primary care diabetes management system, which included targeted guidelines for type 2 diabetes (T2DM) and prediabetes (dysglycemia) screening, on detection of previously undiagnosed dysglycemia cases.

Research Design And Methods: Intervention included electronic health record (EHR)-based decision support and standardized providers and staff training for using the American Diabetes Association guidelines for dysglycemia screening. Using EHR data, we identified 40,456 adults without T2DM or recent screening with a face-to-face visit (March 2011-December 2013) in five urban clinics. Interrupted time series analyses examined the impact of the intervention on trends in three outcomes: ) monthly proportion of eligible patients receiving dysglycemia testing, ) two negative comparison conditions (dysglycemia testing among ineligible patients and cholesterol screening), and ) yield of undiagnosed dysglycemia among those tested.

Results: Baseline monthly proportion of eligible patients receiving testing was 7.4-10.4%. After the intervention, screening doubled (mean increase + 11.0% [95% CI 9.0, 13.0], proportion range 18.6-25.3%). The proportion of ineligible patients tested also increased (+5.0% [95% CI 3.0, 8.0]) with no concurrent change in cholesterol testing (+0% [95% CI -0.02, 0.05]). About 59% of test results in eligible patients showed dysglycemia both before and after the intervention.

Conclusions: Implementation of a policy for systematic dysglycemia screening including formal training and EHR templates in urban academic primary care clinics resulted in a doubling of appropriate testing and the number of patients who could be targeted for treatment to prevent or delay T2DM.

Citing Articles

Evaluation of a Diabetes Screening Clinical Decision Support Tool.

Tseng E, Stein A, Wang N, Mathioudakis N, Yeh H, Maruthur N AJPM Focus. 2024; 3(6):100287.

PMID: 39582738 PMC: 11582736. DOI: 10.1016/j.focus.2024.100287.


Clinical performance and health equity implications of the American Diabetes Association's 2023 screening recommendation for prediabetes and diabetes.

OBrien M, Zhang Y, Bailey S, Khan S, Ackermann R, Ali M Front Endocrinol (Lausanne). 2023; 14:1279348.

PMID: 37900145 PMC: 10611495. DOI: 10.3389/fendo.2023.1279348.


Screening for Prediabetes and Diabetes in a National Network of Federally Qualified Health Centers: An Observational Study.

OBrien M, Bailey S, Gregory D, Owen A, Khan S, Ackermann R J Gen Intern Med. 2023; 38(16):3541-3548.

PMID: 37731136 PMC: 10713898. DOI: 10.1007/s11606-023-08402-1.


Improving Diabetes Screening in the Primary Care Clinic.

Tseng E, Hsu Y, Nigrin C, Clark J, Marsteller J, Maruthur N Jt Comm J Qual Patient Saf. 2023; 49(12):698-705.

PMID: 37704484 PMC: 10828116. DOI: 10.1016/j.jcjq.2023.07.009.


Use of Real-World Data in Population Science to Improve the Prevention and Care of Diabetes-Related Outcomes.

Gregg E, Patorno E, Karter A, Mehta R, Huang E, White M Diabetes Care. 2023; 46(7):1316-1326.

PMID: 37339346 PMC: 10300521. DOI: 10.2337/dc22-1438.


References
1.
Stevens J, Khunti K, Harvey R, Johnson M, Preston L, Woods H . Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes Res Clin Pract. 2015; 107(3):320-31. DOI: 10.1016/j.diabres.2015.01.027. View

2.
Siu A . Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015; 163(11):861-8. DOI: 10.7326/M15-2345. View

3.
Uusitupa M, Peltonen M, Lindstrom J, Aunola S, Ilanne-Parikka P, Keinanen-Kiukaanniemi S . Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial. PLoS One. 2009; 4(5):e5656. PMC: 2682577. DOI: 10.1371/journal.pone.0005656. View

4.
Griffin S, Borch-Johnsen K, Davies M, Khunti K, Rutten G, Sandbaek A . Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet. 2011; 378(9786):156-67. PMC: 3136726. DOI: 10.1016/S0140-6736(11)60698-3. View

5.
Gillett M, Royle P, Snaith A, Scotland G, Poobalan A, Imamura M . Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation. Health Technol Assess. 2012; 16(33):1-236, iii-iv. PMC: 4780928. DOI: 10.3310/hta16330. View